FDA advisers back Moderna's COVID vaccine for kids ages 6 and up
A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Watch CBS News
A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.
The White House says doses will be available everywhere from pediatricians' offices to children's museums, if health authorities sign off on the shots later this month.
Moderna says a new version of its COVID-19 vaccine is superior to its original shots and could be available in late summer.
The FDA's vaccine advisers meet later this month to weigh updating booster shots.
Moderna announced Thursday morning that it's asking the FDA to approve its COVID vaccine for kids under 6 years old. If authorized for emergency use, it would become the first eligible vaccine for kids younger than 5. Nancy Chen spoke to Moderna's chief medical officer as well as a parent of two children who participated in the trial.
Moderna is requesting FDA emergency use authorization for their two-dose COVID-19 vaccine for children under 6. CBS News medical contributor Dr. David Agus joins "CBS Mornings" to break down what this means for families.
Missed the second half of the show? The latest on GOP Rep. Adam Kinzinger of Illinois on the January 6 committee, data on vaccines for kids from Moderna's chief medical officer Paul Burton, and Deborah Birx, former president Donald Trump's COVID-19 response coordinator.
Dr. Paul Burton, Moderna's chief medical officer, says he is "absolutely confident" that data on the company's vaccine for young children will be ready for the FDA to review at its June meeting.
This week on “Face the Nation with Margaret Brennan,” we'll have the latest on Ukraine with Samantha Power, the head of the U.S. Agency for International Development, and Virginia Democratic Sen. Tim Kaine. Then we'll hear from Illinois Rep. Adam Kinzinger; Dr. Paul Burton, the chief medical officer at Moderna; and Dr. Deborah Birx, the COVID-19 response coordinator during the Trump administration.
After a 2-year hiatus caused by the COVID-19 pandemic, the White House correspondents' dinner returns with 2,500 guests in attendance. With cases on the rise and Vice President Kamala Harris testing positive, safety requirements for the event will be strict. Debra Alfarone has more.
Moderna asked the FDA for emergency-use authorization for its COVID-19 vaccine for kids under 6. For those families anxious to inoculate their little ones, the news has them breathing a sigh of relief. Meanwhile, others remain skeptical. Dr. Paul Offit, a pediatrician and member of the FDA's Vaccines and Related Biological Products Advisory Committee, joined CBS News to discuss the upcoming data review.
Moderna is seeking emergency authorization for low doses of its coronavirus vaccine for children under 6, which would be the first COVID-19 vaccine available for children under 5. Epidemiologist Dr. Tom Frieden joined "Red and Blue" to discuss this important step and what to expect in the coming months.
Biden pushes for more aid for Ukraine; Moderna seeks FDA authorization for kids' COVID vaccine
Moderna is seeking emergency-use authorization for a COVID-19 vaccine for use in young children 6 months to under 6 years old. The drugmaker submitted its request to the FDA on Thursday. A decision is expected sometime in June. CBS News medical contributor Dr. David Agus joined CBS News' Mola Lenghi and Nikki Battiste to discuss.
The FDA has pledged to "move with all expediency" to review the company's data on a lower-dose kids' vaccine.
Moderna submitted its request to the FDA for emergency authorization for its vaccine for children under the age of 6. Emergency physician Dr. Jeremy Faust joins "CBS News Mornings" with the latest on that plus new research on treatments for long COVID.
The trials were primarily conducted during COVID's Omicron wave.
Dr. Kizzmekia Corbett is being celebrated for leading a team at the National Institute of Health that helped develop Moderna's COVID-19 vaccine. CBS News' Dr. Jonathan LaPook brings us her story on the last day of Women's History Month.
Dr. Kizzmekia Corbett is being celebrated for leading a team at the National Institutes of Health that helped develop Moderna's COVID-19 vaccine.
The FDA authorized another booster shot of the Moderna or Pfizer COVID vaccines for people 50 and older who want them. Meg Oliver shares more.
The FDA has authorized a second booster dose of Pfizer or Moderna's COVID-19 vaccine for people 50 and older. But some health experts question whether a fourth vaccine dose is needed. CBS News' Meg Oliver reports, and then Dr. Celine Gounder, an infectious disease specialist at NYU and Bellevue Hospital and host of the podcast "Epidemic," joins CBS News' Lana Zak to discuss.
Moderna seeks authorization from the FDA and the CDC for its COVID-19 vaccine for young children. The company says its low-dose vaccine can be given to children as young as 6 months. Moderna's Chief Medical Officer Dr. Paul Burton explains to CBS News' Tanya Rivero and Meg Oliver why, even with a low efficacy rate, the vaccine will save young lives.
Moderna says it will ask the FDA for emergency use authorization for its low-dose COVID vaccine for kids under 6 years old after trials showed promising results. Nancy Chen has the latest.
U.S. health officials currently recommend a primary series of two doses of the Moderna vaccine and a booster dose months later.